1 active not recruiting, 1 completed, 1 withdrawn. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Active not recruiting 1, Completed 1, Withdrawn 1 |
Follow cenegermin: new trials by email Literature Review of cenegermin trials Research Report on cenegermin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Open-label Trial to Evaluate Efficacy and Safety of rhNGF on Corneal Thickness Via AS-OCT in Neurotrophic Keratitis OXERVATE® 0.002% - Neurotrophic Keratitis, Neurotrophic Keratopathy | Phase 4 | Withdrawn | Dompé Farmaceutici S.p.A | 2024-04-26 | 2024-12-02 | |
| DOMPE -MT Neurotrophic Keratitis Cenegermin Ophthalmic Solution [Oxervate] - Dry Eye, Neurotrophic Keratitis | Phase 4 | Active not recruiting | Toyos Clinic | 10 | 2023-01-21 | 2025-04-27 |
| Study to Evaluate OXERVATE® in Patients With Stage 1 Neurotrophic Keratitis cenegermin-bkbj - Neurotrophic Keratitis | Phase 4 | Completed | Dompé Farmaceutici S.p.A | 37 | 2020-09-09 | 2025-11-17 |
Corneal Diseases (1) · Corneal Ulcer (1) · Dry Eye Syndromes (1) · Keratitis (1)
Dompé Farmaceutici S.p.A (2) · Toyos Clinic (1)
United States (2)
Brad Kligman, MD (1) · Flavio Mantelli, MD, PhD (1)